And, as with all equities, purchasing shares of top income stocks on the dip is even better. Here are two brilliant options ...

Motilal Oswal recommended Neutral rating on Bosch with a target price of Rs 34,280 in its research report dated November 12, ...

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

Donald Trump’s first term as president was characterized by significant turbulence for government healthcare programs. Here’s ...

CVS Health faced mixed results in its latest earnings report, revealing revenue growth amid segment struggles.

CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising ...

Good morning and thank you all for attending the CVS Health third-quarter 2024 earnings call and webcast. My name is Brika ...

Meanwhile, among the sector's biggest decliners were hospital operators, with HCA Healthcare Inc.'s stock (HCA) shedding 4.6%, Universal Health Services Inc. shares (UHS) falling 3.7% and shares of ...

CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.